Evidence map›Paper›PMID 25034145›Full record

ArticleLeukemia2014

Synergy of Myc, cell cycle regulators and the Akt pathway in the development of aggressive B-cell lymphoma in a mouse model.

K Arita, S Tsuzuki, K Ohshima, T Sugiyama, M Seto

Abstract readLetter
PubMed Publisher
In one paragraph

Article in Leukemia, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.8field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

K Arita1] Division of Molecular Medicine, Aichi Cancer Center Research Institute, Nagoya, Japan [2] Third Department of Internal Medicine, Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama, Toyama, Japan.
S TsuzukiDivision of Molecular Medicine, Aichi Cancer Center Research Institute, Nagoya, Japan.
K OhshimaDepartment of Pathology, School of Medicine, Kurume University, Kurume, Japan.
T SugiyamaThird Department of Internal Medicine, Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama, Toyama, Japan.
M Seto1] Division of Molecular Medicine, Aichi Cancer Center Research Institute, Nagoya, Japan [2] Department of Pathology, School of Medicine, Kurume University, Kurume, Japan [3] Department of Cancer Genetics, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Aichi Cancer Center · JPKurume University · JPUniversity of Toyama · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AnimalsCell CycleHumansLymphoma, B-CellMice, Inbred NODMice, Mutant StrainsNeoplasm TransplantationProto-Oncogene Proteins c-aktProto-Oncogene Proteins c-mycSignal TransductionMYC protein, humanMyc protein, mouseProto-Oncogene Proteins c-aktProto-Oncogene Proteins c-myc

Identifiers

PMID25034145
OpenAlexW2053117482

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.